How do I buy Gyre Therapeutics (GYRE) stock?

You can purchase shares of Gyre Therapeutics (NASDAQ:GYRE) through any online brokerage.View our list of the best stock brokerages

Who are Gyre Therapeutics (GYRE) competitors?

Other companies in Gyre Therapeutics’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), KalVista Pharmaceuticals Inc (NASDAQ:KALV), CytomX Therapeutics Inc (NASDAQ:CTMX), Valneva SE (NASDAQ:VALN) and MapLight Therapeutics Inc (NASDAQ:MPLT).

What is the forecast, or price target, for Gyre Therapeutics (GYRE) stock?

Gyre Therapeutics has a consensus price target of $17.00.

What is the current price for Gyre Therapeutics (GYRE)?

The stock price for Gyre Therapeutics (NASDAQ: GYRE) is $7.38 last updated January 9, 2026 at 7:05 PM EST.

Does Gyre Therapeutics (GYRE) pay a dividend?

There are no upcoming dividends for Gyre Therapeutics.

When is Gyre Therapeutics (NASDAQ:GYRE) reporting earnings?

Gyre Therapeutics does not have any upcoming earnings scheduled.

Is Gyre Therapeutics (GYRE) going to split?

There is no upcoming split for Gyre Therapeutics.

What sector and industry does Gyre Therapeutics (GYRE) operate in?

Gyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Gyre Therapeutics (GYRE) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-sta...

Comments